RecruitingNot Applicable

Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus Infection

Mexico100 participantsStarted 2025-08-01

Plain-language summary

This 3-year prospective observational study aims to identify clinical and laboratory risk factors associated with hospitalization in patients with confirmed dengue virus infection. It also seeks to analyze real-world transfusion practices and their outcomes. The study will be conducted in a second-level hospital in northern Mexico and will follow patients from emergency department entry to clinical resolution or hospital discharge.

Who can participate

Age range5 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged ≥5 years * Laboratory-confirmed dengue infection (NS1, IgM, or PCR) * First contact at emergency or outpatient services * Informed consent signed by the patient or legal guardian Exclusion Criteria: * Co-infection with other arboviruses or COVID-19 * Pre-existing hematologic or oncologic disease * Refusal to sign informed consent

What they're measuring

Proportion of enrolled patients requiring hospitalization

Timeframe: Time Frame: Within 10 days of symptom onset

Clinical and laboratory risk factors associated with hospitalization

Timeframe: Within 10 days of symptom onset

Trial details

NCT IDNCT07007585

SponsorJose Ivan Rodriguez de Molina Serrano

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-07-31

Contact for this trial

JOSE IVAN RODRIGUEZ DE MOLINA SERRANO, MD, MSc, Ph, Specialist

525525848735 jefe.urgencias@clinicamexico.com

View on ClinicalTrials.gov More Dengue trials